Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Agilent Technologies, Inc. (A)

131.96   0.83 (0.63%) 03-24 16:03
Open: 130.14 Pre. Close: 131.13
High: 131.98 Low: 128.22
Volume: 1,457,523 Market Cap: 39,021(M)

Technical analysis

as of: 2023-03-24 4:23:41 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 164.71     One year: 173.96
Support: Support1: 128.22    Support2: 106.67
Resistance: Resistance1: 141.02    Resistance2: 148.94
Pivot: 136.44
Moving Average: MA(5): 133.67     MA(20): 137.69
MA(100): 147.78     MA(250): 134.9
MACD: MACD(12,26): -3.9     Signal(9): -3.7
Stochastic oscillator: %K(14,3): 14.7     %D(3): 18.7
RSI: RSI(14): 36.8
52-week: High: 160.25  Low: 112.51
Average Vol(K): 3-Month: 1,357 (K)  10-Days: 1,694 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ A ] has closed above bottom band by 16.5%. Bollinger Bands are 3.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 132.05 - 132.7 132.7 - 133.36
Low: 126.7 - 127.37 127.37 - 128.05
Close: 130.86 - 131.94 131.94 - 133.04

Company Description

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Headline News

Fri, 24 Mar 2023
Agilent Technologies Inc. stock rises Friday, outperforms market - MarketWatch

Fri, 24 Mar 2023
Godsey & Gibb Inc. Buys New Position in Agilent Technologies, Inc ... - MarketBeat

Thu, 23 Mar 2023
Agilent Presents 2023 Darlene Solomon Award to Victor Chang ... - Business Wire

Tue, 21 Mar 2023
State of Alaska Department of Revenue Sells 2180 Shares of Agilent ... - MarketBeat

Mon, 20 Mar 2023
Agilent Announced as Instrument Business Outlook 2022 Company ... - Business Wire

Fri, 17 Mar 2023
Agilent Technologies Inc. stock falls Friday, underperforms market - MarketWatch

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 296 (M)
Shares Float 295 (M)
% Held by Insiders 0.2 (%)
% Held by Institutions 89.9 (%)
Shares Short 3,140 (K)
Shares Short P.Month 3,270 (K)

Stock Financials

EPS 2.59
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 15.76
Profit Margin (%) 18.3
Operating Margin (%) 24.4
Return on Assets (ttm) 9.8
Return on Equity (ttm) 23.4
Qtrly Rev. Growth 11.3
Gross Profit (p.s.) 12.56
Sales Per Share 23.13
EBITDA (p.s.) 6.72
Qtrly Earnings Growth -14.7
Operating Cash Flow 1,310 (M)
Levered Free Cash Flow 764 (M)

Stock Valuations

PE Ratio 50.75
PEG Ratio 2.2
Price to Book value 8.37
Price to Sales 5.7
Price to Cash Flow 29.82

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2022-01-25
Ex-Dividend Date 2022-01-02
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.